1. Home
  2. TBPH vs SOHU Comparison

TBPH vs SOHU Comparison

Compare TBPH & SOHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • SOHU
  • Stock Information
  • Founded
  • TBPH 2013
  • SOHU 1996
  • Country
  • TBPH United States
  • SOHU China
  • Employees
  • TBPH N/A
  • SOHU N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • SOHU EDP Services
  • Sector
  • TBPH Health Care
  • SOHU Technology
  • Exchange
  • TBPH Nasdaq
  • SOHU Nasdaq
  • Market Cap
  • TBPH 485.8M
  • SOHU 451.1M
  • IPO Year
  • TBPH N/A
  • SOHU 2000
  • Fundamental
  • Price
  • TBPH $9.15
  • SOHU $13.08
  • Analyst Decision
  • TBPH Buy
  • SOHU
  • Analyst Count
  • TBPH 4
  • SOHU 0
  • Target Price
  • TBPH $13.75
  • SOHU N/A
  • AVG Volume (30 Days)
  • TBPH 166.7K
  • SOHU 50.8K
  • Earning Date
  • TBPH 02-24-2025
  • SOHU 03-03-2025
  • Dividend Yield
  • TBPH N/A
  • SOHU N/A
  • EPS Growth
  • TBPH N/A
  • SOHU N/A
  • EPS
  • TBPH N/A
  • SOHU N/A
  • Revenue
  • TBPH $63,192,000.00
  • SOHU $607,234,000.00
  • Revenue This Year
  • TBPH $11.41
  • SOHU $0.80
  • Revenue Next Year
  • TBPH $37.36
  • SOHU N/A
  • P/E Ratio
  • TBPH N/A
  • SOHU N/A
  • Revenue Growth
  • TBPH 15.93
  • SOHU 98.55
  • 52 Week Low
  • TBPH $7.44
  • SOHU $8.79
  • 52 Week High
  • TBPH $10.44
  • SOHU $17.24
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 49.84
  • SOHU 52.60
  • Support Level
  • TBPH $8.35
  • SOHU $11.66
  • Resistance Level
  • TBPH $8.86
  • SOHU $13.26
  • Average True Range (ATR)
  • TBPH 0.29
  • SOHU 0.35
  • MACD
  • TBPH -0.05
  • SOHU 0.03
  • Stochastic Oscillator
  • TBPH 58.39
  • SOHU 73.20

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About SOHU Sohu.com Limited

Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. The company is involved in the development, operation, and licensing of online games for PCs and mobile devices, which include massively multiplayer online role-playing games, casual games, and strategy games. In addition, it operates focus.cn, which provides online real estate information and services; and 17173.com website, which provides news, electronic forums, online videos, and other online game information services to game players, as well as offers mobile game distribution services. It generates maximum revenue from the Changyou segment.

Share on Social Networks: